China Pharmaceutical: Announcement on Subsidiary Drugs Passing Conformity Assessment of Generic Drugs
China Pharmaceuticals: Announcement on Relinquishing Priority Purchase Rights for Some Shares in Participating Companies
China Pharmaceutical: Announcement of Resolutions of the 22nd Meeting of the 9th Board of Directors
Announcement of Resolutions of the 22nd Meeting of the 9th Board of Directors
Announcement on providing guarantees for holding companies
Announcement on the progress of important shareholding companies planning to change the actual controller
China Pharmaceuticals: Announcement on Subsidiaries Obtaining Drug Registration Approvals
China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications
China Pharmaceutical Investor Relations Activity Record Form
Announcement of Resolutions of the 21st Meeting of the 9th Board of Directors
General Technology Liaoning Pharmaceutical Co., Ltd. 2023 Audit Report
Announcement on renewal of office buildings and related transactions
General Technology Liaoning Pharmaceutical Co., Ltd. Shareholders\' Total Equity Value Asset Assessment Report
Related Party Fund Transaction Management System (2024 Revision)
Notice on the change of accounting firm
Minutes of China Pharmaceutical\'s 2024 Third Quarter Results Briefing
China Pharmaceutical: Announcement on Subsidiary Drugs Passing Conformity Assessment of Generic Drugs
China Pharmaceutical: Notice on Subsidiaries Obtaining Approval Notice for Drug Supplementary Applications
Investor Relations Management Work System (2024 Revision)
Fund Raising Management System (2024 Revision)
No Data